Beyond Air Announces Financial Results Call
Beyond Air, Inc. (NASDAQ: XAIR), a pioneering medical device and biopharmaceutical company, is set to share its financial results for the third fiscal quarter of 2025, marking a significant moment for investors and stakeholders alike. The results, which will cover the period ending December 31, 2024, are scheduled to be announced on Monday at the market’s close.
Details of the Conference Call and Webcast
The upcoming conference call, a platform for the Company to discuss its financials and future outlook, is scheduled for February 10, 2025, at 4:30 PM ET. As a company that is committed to transparency, Beyond Air encourages all stakeholders to participate in this invaluable session.
How to Join the Conference Call
Dial-in options will be available for both domestic and international participants. Those in the U.S. can reach the call by dialing 1-877-407-0784, while international attendees can call 1-201-689-8560. To enhance the experience, participants will need the conference ID: 13750714 to access the call. This is a prime opportunity for interested parties to gain insights directly from the company’s leadership.
Accessing the Live Webcast
For those who prefer a more visual approach, a live webcast of the financial results call will be available. Potential audiences can access it through the Events section of Beyond Air’s official website. Additionally, a replay of the event will also be accessible shortly after the call concludes, ensuring that all interested parties can catch up on the discussions, even if they cannot attend live.
Overview of Beyond Air's Innovative Solutions
Beyond Air specializes in developing and advancing treatments that utilize the potent capabilities of nitric oxide (NO), a molecule known for its therapeutic impacts in various medical scenarios. With a focus on respiratory illnesses, neurological disorders, and certain types of tumors, Beyond Air is at the forefront of medical innovations.
Current and Future Developments
The Company has achieved remarkable milestones, including the FDA approval of its LungFit® PH system, a groundbreaking treatment designed specifically for term and near-term neonates suffering from hypoxic respiratory failure. Beyond Air is also progressing with additional LungFit systems that undergo clinical trials targeted at severe lung infections, including viral pneumonia and non-tuberculous mycobacteria infections.
Collaborative Research Undertakings
Beyond Air is not alone in its mission; partnerships play a crucial role in its research and development endeavors. Notably, the Company has teamed up with prestigious institutions like The Hebrew University of Jerusalem to explore therapies for autism spectrum disorder (ASD) and other neurological ailments. Another aspect of their research investigates an innovative approach to target specific solid tumors using ultra-high concentrations of nitric oxide through a proprietary delivery system.
Stay Informed with Beyond Air
As Beyond Air prepares for its next analysts and investors’ call, it continues to maintain an open line of communication with its stakeholders, reflecting its dedicated approach to enhancing patient care and delivering impactful medical solutions. With a rapidly evolving landscape in medical technology, Beyond Air’s commitment is clear: to harness science and innovation to change lives for the better.
Frequently Asked Questions
What is the purpose of the conference call?
The conference call aims to present Beyond Air's financial results for the third fiscal quarter of 2025 and discuss future strategies.
How can I attend the webcast?
You can join the webcast by visiting the Events section of Beyond Air’s official website on the day of the call.
What innovations is Beyond Air working on?
Beyond Air is advancing therapies using nitric oxide for treating respiratory illnesses, neurological disorders, and more.
Is there a way to view the call after it concludes?
Yes, a replay of the call will be available on the Company's website shortly after the event ends.
Who can I contact for more information?
For inquiries, you can contact Corey Davis, Ph.D. at LifeSci Advisors, or reach out via email at Cdavis@lifesciadvisors.com.
